Finance

Lists
41O:FRA
Outlook Therapeutics Inc
€0.45
0.00%
(0.00) 1D
Oct 19, 4:57:01 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 41O...
Mkt. cap
119.58M
Avg. vol.
1.41K
Volume
0.00
52-wk high
€2.26
52-wk low
€0.15
No. of employees
17
Mkt. cap
119.58M
Avg. vol.
1.41K
Volume
0.00
52-wk high
€2.26
52-wk low
€0.15
No. of employees
17
News stories
From web sources and news partners
About Outlook Therapeutics Inc
CEO-
Employees17
Founded2010
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-91.79K
-1.21M
127.44K
8.70K
Cost of goods sold
916.52K
29.63K
149.33K
16.96K
Cost of revenue
916.52K
29.63K
149.33K
16.96K
Research and development expenses
5.98M
3.63M
4.50M
3.25M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.33M
8.61M
9.50M
7.55M
Operating expense
16.31M
12.25M
14.01M
10.80M
Total operating expenses
17.22M
12.28M
14.15M
10.82M
Operating income
-17.31M
-13.48M
-14.03M
-10.81M
Other non operating income
3.02M
-2.79M
6.84M
-7.04M
EBT including unusual items
-14.85M
-23.06M
-4.45M
-20.32M
EBT excluding unusual items
-14.51M
-16.31M
-7.23M
-17.89M
Income tax expense
-1.55M
-
-
-
Effective tax rate
10.47%
-
-
-
Other operating expenses
-
-
-
-
Net income
-13.29M
-23.06M
-4.45M
-20.32M
Net profit margin
14,482.19%
1,909.05%
-3,494.28%
-233,554.85%
Earnings per share
-0.29
-0.22
-0.17
-0.09
Interest and investment income
89.74K
-
3.00
7.00
Interest expense
-264.16K
-
-
-
Net interest expenses
-174.42K
-
3.00
7.00
Depreciation and amortization charges
-
-
-
-
EBITDA
-17.28M
-13.45M
-14.00M
-10.80M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps